First Time Loading...

Sorrento Therapeutics Inc
NASDAQ:SRNE

Watchlist Manager
Sorrento Therapeutics Inc Logo
Sorrento Therapeutics Inc
NASDAQ:SRNE
Watchlist
Price: 0.3322 USD 8.92% Market Closed
Updated: May 21, 2024

Sorrento Therapeutics Inc
Other Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Sorrento Therapeutics Inc
Other Operating Expenses Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Other Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Other Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
Sorrento Therapeutics Inc
NASDAQ:SRNE
Other Operating Expenses
$75.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Other Operating Expenses
$169m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Gilead Sciences Inc
NASDAQ:GILD
Other Operating Expenses
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Other Operating Expenses
-$791m
CAGR 3-Years
-52%
CAGR 5-Years
-20%
CAGR 10-Years
-7%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Other Operating Expenses
$49.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Other Operating Expenses
-$13.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Sorrento Therapeutics Inc's Other Operating Expenses?
Other Operating Expenses
75.4m USD

Based on the financial report for Dec 31, 2022, Sorrento Therapeutics Inc's Other Operating Expenses amounts to 75.4m USD.